The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities

Published:2017-12-19 Issue:2 Volume:18 Page:131-148
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Tesfaye Anteneh A.¹²^ORCID,Kamgar Mandana¹²,Azmi Asfar¹²,Philip Philip A.¹²³

Affiliation:

1. Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA

2. Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA

3. Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, USA

Funder

National Institute of Health

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1417844

Reference211 articles.

1. Cancer statistics, 2017

2. Perioperative management of pancreatic cancer

3. Personalising pancreas cancer treatment: When tissue is the issue

4. Survival Among Patients with Adenocarcinoma of the Pancreas: A Population-based Study (United States)

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies;Frontiers in Oncology;2024-03-25

2. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma;Frontiers in Immunology;2024-02-07

3. Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

4. Identification of Potential Biomarkers associated with Prognosis and Pathogenesis of Pancreatic Cancer;2023-12-08

5. A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review;Oncology Letters;2023-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3